🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of the study is to compare the effectiveness of nivolum...
Status
Completed
Location
Local Institution - 0119
Start Date
2019-10-08
Trial ID
NCT04026412
Treatments Being Tested
This is a phase Ib/II, open-label, single-arm, multicenter study to investi...
Status
Unknown
Location
National Cancer Center Hospital East
Start Date
2016-10
Trial ID
NCT02948348
Treatments Being Tested
This platform trial will evaluate various immunotherapy combinations given ...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2016-03-28
Trial ID
NCT02451982
Treatments Being Tested
Nivolumab (BMS-936558) is a fully human, IgG4 (kappa) isotype mAb that bind...
Status
Active Not Recruiting
Location
Guangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Start Date
2019-08-08
Trial ID
NCT04015778
This trial is to investigate the use of nivolumab in sequence with standard...
Status
Completed
Location
Clatterbridge Cancer Centre NHS Foundation Trust
Start Date
2019-05-10
Trial ID
NCT03721757
Treatments Being Tested
This is a single-center cross-sectional imaging and correlative biomarker s...
Status
Completed
Location
Stanford Hospital and Clinics
Start Date
2017-05-01
Trial ID
NCT03129061
The purpose of this study is to investigate the level of Circulating Tumor ...
Status
Completed
Location
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Start Date
2014-05
Trial ID
NCT02449837
Treatments Being Tested
This is a Phase I/II study to determine the safety and immune response of t...
Status
Withdrawn
Location
National Institutes of Health Clinical Center
Start Date
2024-08-02
Trial ID
NCT05898828
Treatments Being Tested
Three parallel cohort, multicenter, open-label, phase I/II clinical trial t...
Status
Active Not Recruiting
Location
Oslo University Hospital
Start Date
2018-04-26
Trial ID
NCT03544736
Treatments Being Tested
This pilot phase I/II trial studies the side effects and how well nivolumab...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2019-01-07
Trial ID
NCT03776487